Literature DB >> 19249271

Personality, addiction, dopamine: insights from Parkinson's disease.

Alain Dagher1, Trevor W Robbins.   

Abstract

In rare instances, patients with Parkinson's disease (PD) may become addicted to their own medication or develop behavioral addictions such as pathological gambling. This is surprising because PD patients typically have a very low incidence of drug abuse and display a personality type that is the polar opposite of the addictive personality. These rare addictive syndromes, which appear to result from excessive dopaminergic medication use, illustrate the link between dopamine, personality, and addiction. We describe the clinical phenomena and attempt to relate them to current models of learning and addiction. We conclude that persistently elevated dopaminergic stimulation promotes the development and maintenance of addictive behaviors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249271     DOI: 10.1016/j.neuron.2009.01.031

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  103 in total

Review 1.  From reinforcement learning models to psychiatric and neurological disorders.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Nat Neurosci       Date:  2011-02       Impact factor: 24.884

Review 2.  Introduction to behavioral addictions.

Authors:  Jon E Grant; Marc N Potenza; Aviv Weinstein; David A Gorelick
Journal:  Am J Drug Alcohol Abuse       Date:  2010-09       Impact factor: 3.829

Review 3.  Impulse control disorders in Parkinson's disease: the role of personality and cognitive status.

Authors:  Michele Poletti; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

Review 4.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

5.  Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.

Authors:  Kalen Petersen; Nelleke Van Wouwe; Adam Stark; Ya-Chen Lin; Hakmook Kang; Paula Trujillo-Diaz; Robert Kessler; David Zald; Manus J Donahue; Daniel O Claassen
Journal:  Hum Brain Mapp       Date:  2017-10-31       Impact factor: 5.038

Review 6.  Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.

Authors:  Alexander M Lopez; Daniel Weintraub; Daniel O Claassen
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

Review 7.  Establishing causality for dopamine in neural function and behavior with optogenetics.

Authors:  Elizabeth E Steinberg; Patricia H Janak
Journal:  Brain Res       Date:  2012-09-29       Impact factor: 3.252

8.  Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task.

Authors:  Robb B Rutledge; Stephanie C Lazzaro; Brian Lau; Catherine E Myers; Mark A Gluck; Paul W Glimcher
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

9.  Extremely low-frequency magnetic field exposure, electrical shocks and risk of Parkinson's disease.

Authors:  Marianne van der Mark; Roel Vermeulen; Peter C G Nijssen; Wim M Mulleners; Antonetta M G Sas; Teus van Laar; Hans Kromhout; Anke Huss
Journal:  Int Arch Occup Environ Health       Date:  2014-06-18       Impact factor: 3.015

10.  Increased motor impulsivity in a rat gambling task during chronic ropinirole treatment: potentiation by win-paired audiovisual cues.

Authors:  Melanie Tremblay; Michael M Barrus; Paul J Cocker; Christelle Baunez; Catharine A Winstanley
Journal:  Psychopharmacology (Berl)       Date:  2019-01-31       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.